Stage I Breast Carcinoma Recruiting Phase 3 Trials for Pembrolizumab (DB09037)

Also known as: Early Breast cancer / Breast Cancer Stage I / Carcinoma Breast Stage I / Breast Cancer, Stage I / Stage I Breast Cancer / Breast carcinoma stage I / Breast carcinoma NOS stage I / Breast cancer NOS stage I

IndicationStatusPhase
DBCOND0059537 (Stage I Breast Carcinoma)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02954874Pembrolizumab in Treating Patients With Triple-Negative Breast CancerTreatment